Dogwood Therapeutics

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$1.62-$21.78
Market Cap
$8.1M
Shares Short
87,277

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$0
Diluted EPS
-$6.32

News

See more

Yahoo Finance • last month

Dogwood Therapeutics Announces Patient Dosing in Phase 2b Trial Evaluating Halneuron® in Patients with Chemotherapy Induced Neuropathy (CINP) to Commence First Quarter of 2025

About

CEO
Mr. Gregory Duncan
Address
44 Milton Avenue, Alpharetta, GA, United States, 30009
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
4